Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(8):670-671; doi:10.1093/jnci/91.8.670a
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bankhead, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bankhead, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 8, 670-671, April 21, 1999
© 1999 Oxford University Press

NEWS

Bristol Award: Fidler Honored For Metastasis Research

Charles Bankhead

A would-be surgeon who has spent most of his career in laboratories, Isaiah Fidler, D.V.M., Ph.D., remains devoted to the field of cancer biology that he helped revolutionize.



View larger version (129K):
[in this window]
[in a new window]
  		Dr. Isaiah Fidler

 
"Without serious biology, there cannot be advancement in therapy," says Fidler, the 1999 recipient of the prestigious Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. "The clinical trials of tomorrow are based on the basic research of today. Continued encouragement of basic research is the most important issue — not an emphasis on the molecule of the day."

Fidler was honored . . . [Full Text of this Article]

No Regrets


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?